论文信息 - Technetium-99m labeled Somatostatin analogues and their role in the Management of Patients with Neuroendocrine Tumors. - 字舞流文

Technetium-99m labeled Somatostatin analogues and their role in the Management of Patients with Neuroendocrine Tumors.

R. Mikołajczak

[1] J. Walecki,et al. Initial Direct Comparison of 99mTc-TOC and 99mTc-TATE in Identifying Sites of Disease in Patients with Proven GEP NETs , 2008, Journal of Nuclear Medicine.

[2] R. Bale,et al. 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT , 2007, Journal of Nuclear Medicine.

[3] A. Hubalewska-Dydejczyk,et al. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience , 2006, European Journal of Nuclear Medicine and Molecular Imaging.